Aspen: The drug replacing semaglutide has been approved in South Africa for chronic weight management
On October 13th, it was reported that Aspen Pharmacare announced that the South African Health Products Regulatory Authority has approved its once-weekly prescription treatment drug Mounjaro for an additional indication, to be used as an adjunct to diet and exercise for chronic weight management, effective from October
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments